Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Globe Newswire News Releases

Dec 12, 2019 08:00 ET
Inspire Announces the Appointment of Two Clean Technology Pioneers to its Board
Inspire, one of the fastest-growing clean technology companies in the U.S., today announced the appointment of clean energy leaders David Crane and Andrew Beebe to its Board. The industry pioneers join at a time when Inspire is experiencing record...
Dec 12, 2019 08:00 ET
Japan maps and navigation get AI boost with Hitachi, Mapbox partnership
Hitachi Solutions (HISOL) and Mapbox have announced a partnership to sell Mapbox licenses into Japan, a reseller arrangement that will open new opportunities for Japan and globally-based companies to provide AI maps and navigation services into...
Dec 12, 2019 08:00 ET
Kaleido Biosciences to Advance KB174 for Hepatic Encephalopathy Based on Positive Top-Line Results from a Clinical Study in Patients with Cirrhosis
Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a chemistry-driven approach to leveraging the microbiome organ to treat disease and improve human health, today announced positive top-line results from a...
Dec 12, 2019 08:00 ET
Northland Power Announces Renewal of Normal Course Issuer Bid
Northland Power Inc. (“Northland”) (TSX: NPI) announces that the Toronto Stock Exchange (“TSX”) has accepted its notice of intention to renew its normal course issuer bid (“NCIB”) commencing December 17, 2019 and ending December 16, 2020....
Dec 12, 2019 08:00 ET
Pieridae Updates 2020 Guidance
Pieridae Energy Limited (“Pieridae” or the “Company”) (PEA - TSXV) released updated corporate guidance for 2020 today which focuses on increasing NOI due to, among other things, operating efficiencies; increasing production with the recent,...
Dec 12, 2019 08:00 ET
Provectus Announces Presentation of Preliminary Results from Phase 1 Trial of PV-10® (rose bengal disodium) for Treatment of Metastatic Uveal Melanoma at ESMO I-O Congress 2019
Provectus (OTCQB: PVCT) today announced that data from the Company's ongoing Phase 1 study of lysosomal-targeting cancer immunotherapy PV-10 (rose bengal disodium) as a single-agent and in combination with standard of care immune checkpoint...
Dec 12, 2019 08:00 ET
REPEAT - AgraFlora Organics Completes UK Home Office Controlled Drug Handling License Inspection
AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF), a growth oriented and diversified international cannabis company, is pleased to announce that the Company’s United Kingdom (the “UK”)...
Dec 12, 2019 08:00 ET
Salarius Pharmaceuticals to Present Trial-in-Progress Poster at Epigenetics Symposium: 15 Years of Lysine Demethylases: From Discovery to the Clinic
Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biotechnology company targeting the epigenetic causes of cancer, announced today the acceptance of an abstract at the “Epigenetics Symposium: 15 Years of Lysine Demethylases: From...
Dec 12, 2019 08:00 ET
Secure Technology Alliance Announces New TWIC Security Training and Certification Program
The Secure Technology Alliance announced today a new training and certification program for professionals responsible for implementing Transportation Worker Identification Credential (TWIC) security in the U.S. The Transportation Security Certified...
Dec 12, 2019 08:00 ET
Warren Wang CEO of, Inc., is Featured in a New Interview at Inc. and, Inc. (OTCQB: CIIX) ("CIIX" or "the Company"), an established financial news and investment portal, as well as a leading industrial hemp retailer for the Chinese-speaking community today announced...
Dec 12, 2019 07:59 ET
Discovery Metals Announces Result of Special Meeting of Shareholders
Discovery Metals Corp. (“Discovery” or “the Company”) (TSXV: DSV, OTCQX: DSVMF) is pleased to announce that at a special meeting of the Company’s shareholders on December 11, 2019, Discovery’s shareholders passed a resolution approving 2176423...
Dec 12, 2019 07:59 ET
United Hunter Oil & Gas Corp. Provides Greater Detail on the Assignment Agreement with Texaskew Energy, LLC
UNITED HUNTER OIL & GAS CORP. (TSX.V:UHO) (the “Corporation” or “United Hunter”) is pleased to announce that it has entered into an assignment agreement (the “Agreement”) dated December 9, 2019 with Texaskew Energy, LLC (“Texaskew”) pursuant to...
Dec 12, 2019 07:58 ET
Veritas Farms Expands Operations with Lease of Aurora, Colorado 34,000 Square Foot Production and Distribution Facility
via NEWMEDIAWIRE -- Veritas Farms, Inc. (OTCQB:VFRM) “Veritas Farms” or the “Company”, a vertically integrated agribusiness focused on the production of full spectrum hemp oil products with naturally occurring cannabinoids, is pleased to announce...
Dec 12, 2019 07:50 ET
Assertio Therapeutics Announces Sale of Gralise® for Total Transaction Value of $127.5 Million
Assertio Therapeutics, Inc. (“Assertio”) (NASDAQ: ASRT), today announced it has entered into an agreement with Alvogen, a global privately held pharmaceutical company, under which Alvogen will acquire and assume all responsibilities associated with...
Dec 12, 2019 07:42 ET
Blue Hens Announce New Relationship with Paciolan
Paciolan, the leading ticketing solution provider for college athletics, has entered into a relationship with the University of Delaware Athletics. Paciolan will provide Delaware Athletics with a cohesive solution that integrates digital ticketing,...
Dec 12, 2019 07:30 ET
CB2 Insights Completes Full-Scale Platform to Connect Disparate Data Systems
CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), a leading data-driven company focused on bringing real-world evidence driven from the point-of-care to the medical cannabis community, today announced its core technology platform,...
Dec 12, 2019 07:30 ET
FTI Consulting Launches LIBOR Transition Task Force
FTI Consulting, Inc. (NYSE: FCN) today announced the formal launch of its LIBOR Transition Task Force, a multidisciplinary group that leverages expertise from across the firm to help clients successfully navigate the transition from LIBOR to...
Dec 12, 2019 07:30 ET
Intra-Cellular Therapies Highlights Lumateperone Presentations at the 58th Annual Meeting of the American College of Neuropsychopharmacology
Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced data featured yesterday during the 58th Annual Meeting of the American...
Dec 12, 2019 07:30 ET
James E. Wagner Cultivation to Open Farm-gate Store at Kitchener, Ontario Cultivation Facility
James E. Wagner Cultivation Corporation (JWC) (TSX: JWCA.V; OTCQX: JWCAF), plans to open a 2,000 sf. farm-gate retail store adjoining its 340,000 sf. flagship cultivation facility located at 530 Manitou Drive in Kitchener, Ontario. As JWC scales...
Dec 12, 2019 07:30 ET
Marinus Pharmaceuticals Appoints Elan Ezickson to Board of Directors
Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS) (“Marinus” or “Company”), a pharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy, depression and other neuropsychiatric disorders, announced today that Elan...